385 related articles for article (PubMed ID: 23549982)
21. Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: A systematic review and meta-analysis.
Legendre L; Barnetche T; Mazereeuw-Hautier J; Meyer N; Murrell D; Paul C
J Am Acad Dermatol; 2015 Jun; 72(6):992-1002. PubMed ID: 25840730
[TBL] [Abstract][Full Text] [Related]
22. A practical algorithm for topical treatment of atopic dermatitis in the Middle East emphasizing the importance of sensitive skin areas.
Reda AM; Elgendi A; Ebraheem AI; Aldraibi MS; Qari MS; Abdulghani MMR; Luger T
J Dermatolog Treat; 2019 Jun; 30(4):366-373. PubMed ID: 30222017
[No Abstract] [Full Text] [Related]
23. A Comparison of Topical Corticosteroids and Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis.
Pena J; Zameza PA; Pixley JN; Remitz A; Feldman SR
J Allergy Clin Immunol Pract; 2023 May; 11(5):1347-1359. PubMed ID: 36997119
[TBL] [Abstract][Full Text] [Related]
24. Unmet medical needs in the treatment of atopic dermatitis in infants: An Expert consensus on safety and efficacy of pimecrolimus.
Luger T; Augustin M; Lambert J; Paul C; Pincelli C; Torrelo A; Vestergaard C; Wahn U; Werfel T
Pediatr Allergy Immunol; 2021 Apr; 32(3):414-424. PubMed ID: 33251600
[TBL] [Abstract][Full Text] [Related]
25. Topical tacrolimus in adult atopic dermatitis: a consensus based on a 15-year experience.
Calzavara-Pinton P; Fabbrocini G; Girolomoni G; Matiucci A; Micali G; Musumeci ML; Patruno C; Pellacani G; Rossi MT; Castello M; Stingeni L
G Ital Dermatol Venereol; 2020 Feb; 155(1):8-13. PubMed ID: 31760730
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and economics of topical calcineurin inhibitors for the treatment of atopic dermatitis.
Abramovits W; Hung P; Tong KB
Am J Clin Dermatol; 2006; 7(4):213-22. PubMed ID: 16901181
[TBL] [Abstract][Full Text] [Related]
28. Topical calcineurin inhibitors in atopic dermatitis: a systematic review and meta-analysis.
El-Batawy MM; Bosseila MA; Mashaly HM; Hafez VS
J Dermatol Sci; 2009 May; 54(2):76-87. PubMed ID: 19303745
[TBL] [Abstract][Full Text] [Related]
29. Off-label topical calcineurin inhibitor use in children.
Manthripragada AD; Pinheiro SP; MaCurdy TE; Saneinejad S; Worrall CM; Kelman JA; Graham DJ
Pediatrics; 2013 Nov; 132(5):e1327-32. PubMed ID: 24127469
[TBL] [Abstract][Full Text] [Related]
30. Review of Atopic Dermatitis and Topical Therapies.
Mayba JN; Gooderham MJ
J Cutan Med Surg; 2017; 21(3):227-236. PubMed ID: 28300440
[TBL] [Abstract][Full Text] [Related]
31. Topical calcineurin inhibitors and risk of lymphoma: a systematic review and meta-analysis.
Wu PC; Huang IH; Liu CW; Huang YC
J Dtsch Dermatol Ges; 2021 Sep; 19(9):1265-1269. PubMed ID: 34390192
[TBL] [Abstract][Full Text] [Related]
32. Systematic review on the efficacy, safety, and cost-effectiveness of topical calcineurin inhibitors in atopic dermatitis.
Chia BK; Tey HL
Dermatitis; 2015; 26(3):122-32. PubMed ID: 25984688
[TBL] [Abstract][Full Text] [Related]
33. Corticosteroid therapy in the treatment of pediatric patients with atopic dermatitis.
Fröschl B; Arts D; Leopold C
GMS Health Technol Assess; 2007 Sep; 3():Doc09. PubMed ID: 21289943
[TBL] [Abstract][Full Text] [Related]
34. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies.
Eichenfield LF; Tom WL; Berger TG; Krol A; Paller AS; Schwarzenberger K; Bergman JN; Chamlin SL; Cohen DE; Cooper KD; Cordoro KM; Davis DM; Feldman SR; Hanifin JM; Margolis DJ; Silverman RA; Simpson EL; Williams HC; Elmets CA; Block J; Harrod CG; Smith Begolka W; Sidbury R
J Am Acad Dermatol; 2014 Jul; 71(1):116-32. PubMed ID: 24813302
[TBL] [Abstract][Full Text] [Related]
35. Topical calcineurin inhibitors in the treatment of atopic dermatitis - an update on safety issues.
Czarnecka-Operacz M; Jenerowicz D
J Dtsch Dermatol Ges; 2012 Mar; 10(3):167-72. PubMed ID: 21974750
[TBL] [Abstract][Full Text] [Related]
36. Role of topical calcineurin inhibitors on atopic dermatitis of children.
Ricci G; Dondi A; Patrizi A
Curr Med Chem; 2007; 14(14):1579-91. PubMed ID: 17584066
[TBL] [Abstract][Full Text] [Related]
37. The topical calcineurin inhibitor pimecrolimus in atopic dermatitis: a safety update.
Thaçi D; Salgo R
Acta Dermatovenerol Alp Pannonica Adriat; 2007 Jun; 16(2):58, 60-62. PubMed ID: 17992459
[TBL] [Abstract][Full Text] [Related]
38. Tacrolimus ointment for the treatment of adult and pediatric atopic dermatitis: Review on safety and benefits.
Ohtsuki M; Morimoto H; Nakagawa H
J Dermatol; 2018 Aug; 45(8):936-942. PubMed ID: 29927498
[TBL] [Abstract][Full Text] [Related]
39. Association Between the Use of Topical Calcineurin Inhibitors and the Risk of Cancer Among Patients with Atopic Dermatitis: A Nationwide, Population-Based, Retrospective Cohort Study.
Huang HH; Shen D; Chan TC; Cho YT; Tang CH; Chu CY
Am J Clin Dermatol; 2023 Sep; 24(5):799-808. PubMed ID: 37280416
[TBL] [Abstract][Full Text] [Related]
40. [Not Available].
Darrigade AS
Ann Dermatol Venereol; 2019 Dec; 146(12S3):12S85-12S95. PubMed ID: 31997737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
